These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32907365)

  • 1. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020).
    Zhang X; Tan R; Lam WC; Yao L; Wang X; Cheng CW; Liu F; Chan JC; Aixinjueluo Q; Lau CT; Chen Y; Yang K; Wu T; Lyu A; Bian Z
    Am J Chin Med; 2020; 48(6):1279-1313. PubMed ID: 32907365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting quality of Cochrane systematic reviews with Chinese herbal medicines.
    Zhang X; Aixinjueluo QY; Li SY; Song LL; Lau CT; Tan R; Bian ZX
    Syst Rev; 2019 Dec; 8(1):302. PubMed ID: 31796121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):112-121. PubMed ID: 28654980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration.
    Zhang X; Tan R; Lam WC; Cheng CW; Yao L; Wang XQ; Li SY; Aixinjueluo QY; Yang KH; Shang HC; Wu TX; Lyu AP; Bian ZX
    Syst Rev; 2020 Oct; 9(1):247. PubMed ID: 33100229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a reporting guideline for systematic reviews of animal experiments in the field of traditional Chinese medicine.
    Zhao B; Hu K; Zeng X; Kwong JSW; Li B; Chen H; Tian G; Xiong J; Li Z; Niu J; Jiao M; Yang J; Ding F; Liu C; Du L; Zhang J; Ma B
    J Evid Based Med; 2022 Jun; 15(2):152-167. PubMed ID: 35775104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist.
    Wang X; Chen Y; Liu Y; Yao L; Estill J; Bian Z; Wu T; Shang H; Lee MS; Wei D; Tian J; Ma B; Wang Y; Tian G; Yang K
    BMC Complement Altern Med; 2019 Aug; 19(1):208. PubMed ID: 31405367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese Herbal Medicine for the Treatment of Adult Viral Myocarditis: An Overview of Systematic Reviews and Meta-analyses of Randomized Controlled Trials.
    Hui XS; Wang SQ; Lu SC; Liu YM; Zhang ZP; Lian WJ; Zhou SY; Zhang H; Zhang JS; Wang J
    Clin Ther; 2023 Oct; 45(10):991-1003. PubMed ID: 37690913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration.
    Zhang X; Lan L; Chan JCP; Zhong LLD; Cheng CW; Lam WC; Tian R; Zhao C; Wu TX; Shang HC; Lyu AP; Bian ZX
    BMC Med Res Methodol; 2020 Jul; 20(1):192. PubMed ID: 32680474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and Safety of Chinese Herbal Medicine in Treating Psoriasis: An Overview of Systematic Reviews.
    Zhang J; Yu Q; Peng L; Qin Y; Jing M; Huang D; Guo J; Xiao M; Chen M
    Front Pharmacol; 2021; 12():680172. PubMed ID: 34276371
    [No Abstract]   [Full Text] [Related]  

  • 10. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
    Hutton B; Salanti G; Caldwell DM; Chaimani A; Schmid CH; Cameron C; Ioannidis JP; Straus S; Thorlund K; Jansen JP; Mulrow C; Catalá-López F; Gøtzsche PC; Dickersin K; Boutron I; Altman DG; Moher D
    Ann Intern Med; 2015 Jun; 162(11):777-84. PubMed ID: 26030634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting and Methodological Quality of Systematic Reviews and Meta-Analyses of Nursing Interventions in Patients With Alzheimer's Disease: General Implications of the Findings.
    Sun X; Zhou X; Zhang Y; Liu H
    J Nurs Scholarsh; 2019 May; 51(3):308-316. PubMed ID: 30806019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Systematic Reviews of Chinese Herbal Medicine in the Treatment of Migraines.
    Fu G; Fan X; Liang X; Wei J; Jia M; Liu S; Shen W; Zhang Y
    Front Pharmacol; 2022; 13():924994. PubMed ID: 35959435
    [No Abstract]   [Full Text] [Related]  

  • 13. Methodological quality of systematic reviews on Chinese herbal medicine: a methodological survey.
    Cheung AKL; Wong CHL; Ho L; Wu IXY; Ke FYT; Chung VCH
    BMC Complement Med Ther; 2022 Feb; 22(1):48. PubMed ID: 35197038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the quality of randomized controlled trials in Chinese herbal medicine, part IV: applying a revised CONSORT checklist to measure reporting quality.
    Bian ZX; Moher D; Dagenais S; Li YP; Wu TX; Liu L; Miao JX; Song L; Zhang HM
    Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):233-42. PubMed ID: 16696907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preferred reporting items for systematic reviews and meta-analyses in ecology and evolutionary biology: a PRISMA extension.
    O'Dea RE; Lagisz M; Jennions MD; Koricheva J; Noble DWA; Parker TH; Gurevitch J; Page MJ; Stewart G; Moher D; Nakagawa S
    Biol Rev Camb Philos Soc; 2021 Oct; 96(5):1695-1722. PubMed ID: 33960637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures of chinese herbal medicine for coronary heart disease: an overview of systematic reviews.
    Luo J; Xu H
    Evid Based Complement Alternat Med; 2012; 2012():927392. PubMed ID: 22606207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
    McInnes MDF; Moher D; Thombs BD; McGrath TA; Bossuyt PM; ; Clifford T; Cohen JF; Deeks JJ; Gatsonis C; Hooft L; Hunt HA; Hyde CJ; Korevaar DA; Leeflang MMG; Macaskill P; Reitsma JB; Rodin R; Rutjes AWS; Salameh JP; Stevens A; Takwoingi Y; Tonelli M; Weeks L; Whiting P; Willis BH
    JAMA; 2018 Jan; 319(4):388-396. PubMed ID: 29362800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
    Stewart LA; Clarke M; Rovers M; Riley RD; Simmonds M; Stewart G; Tierney JF;
    JAMA; 2015 Apr; 313(16):1657-65. PubMed ID: 25919529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topics and PRISMA Checklist Compliance for Meta-analyses in Dermatology: Journal Case Study.
    Poveda-Montoyo I; Belinchón-Romero I; Romero-Pérez D; Ramos-Rincón JM
    Acta Dermatovenerol Croat; 2019 Dec; 27(4):275-277. PubMed ID: 31969243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
    Liberati A; Altman DG; Tetzlaff J; Mulrow C; Gøtzsche PC; Ioannidis JP; Clarke M; Devereaux PJ; Kleijnen J; Moher D
    J Clin Epidemiol; 2009 Oct; 62(10):e1-34. PubMed ID: 19631507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.